Research Projects

SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma, a rare hematologic disease (CARAMBA)

Research program
Multiple myeloma

Project information

CARAMBA will be the first clinical trial targeting the myeloma-specific protein SLAMF7. The project's mission is to better understand the role of CAR-T therapy in myeloma and to explore sustainable regulatory and funding approaches so that healthcare systems can ensure patient access to this type of innovation.

  • Convocation: 2018-2022
  • Reference: 754658
  • Start date: January 1, 2018
  • End date: April 30, 2022
  • Funder: Comisión Europea
  • Grant: € 6 097 875
  • Nature of project: International
  • Award year 2017

Need more information?

If you are interested in learning more about our research, please contact us.